Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD
- PMID: 32583212
- DOI: 10.1007/s11064-020-03076-1
Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD
Abstract
Accumulation of amyloid-β (Aβ) peptides in the brain is regarded as a major contributor to the pathogenesis and progression of Alzheimer's disease (AD). P-glycoprotein (P-gp) as a member of ABC transporter family situated in blood brain barrier (BBB) plays a role on cleaning of Aβ via its efflux transport effect in the treatment of AD. However, the expression of P-gp in pathological BBB was lower than that in normal BBB, thus impeding the clearance of Aβ. Here, we used human brain microvascular endothelial cells (HBMVECs) derived exosomes (HBMVECs-Ex) inheriting P-gp as an extracorporeal Aβ cleansing system to remove Aβ peptides from the brain by specific capture between P-gp and Aβ. The results showed that HBMVECs-Ex inheriting P-gp greatly facilitated the cerebral clearance of Aβ by effectively transporting Aβ out of brain and potently ameliorated cognitive dysfunction in AD mice. Taken together, HBMVECs-Ex provided a new strategy on the treatment of AD.
Keywords: Alzheimer’s disease; Amyloid-β; Blood–brain barrier; HBMVECs-Ex; P-glycoprotein.
Similar articles
-
Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.Curr Alzheimer Res. 2017;14(6):656-667. doi: 10.2174/1567205013666161201201227. Curr Alzheimer Res. 2017. PMID: 27915995
-
Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.Fluids Barriers CNS. 2023 Oct 6;20(1):70. doi: 10.1186/s12987-023-00470-z. Fluids Barriers CNS. 2023. PMID: 37803468 Free PMC article.
-
P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?FEBS J. 2020 Feb;287(4):612-625. doi: 10.1111/febs.15148. Epub 2019 Dec 9. FEBS J. 2020. PMID: 31750987 Review.
-
The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.Brain Behav Immun. 2018 Oct;73:21-33. doi: 10.1016/j.bbi.2018.07.017. Epub 2018 Jul 21. Brain Behav Immun. 2018. PMID: 30041013 Free PMC article.
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
Cited by
-
Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease.Front Cell Neurosci. 2021 Jul 19;15:695479. doi: 10.3389/fncel.2021.695479. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34349624 Free PMC article. Review.
-
The potential value of exosomes as adjuvants for novel biologic local anesthetics.Front Pharmacol. 2023 Jan 26;14:1112743. doi: 10.3389/fphar.2023.1112743. eCollection 2023. Front Pharmacol. 2023. PMID: 36778004 Free PMC article. Review.
-
Extracellular vesicle therapy in neurological disorders.J Biomed Sci. 2024 Aug 25;31(1):85. doi: 10.1186/s12929-024-01075-w. J Biomed Sci. 2024. PMID: 39183263 Free PMC article. Review.
-
Roles of Exosomes and Exosomal MicroRNAs in Postoperative Sleep Disturbance.Nat Sci Sleep. 2021 Jul 30;13:1363-1375. doi: 10.2147/NSS.S310351. eCollection 2021. Nat Sci Sleep. 2021. PMID: 34354381 Free PMC article. Review.
-
Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.Int J Mol Sci. 2021 Jan 27;22(3):1231. doi: 10.3390/ijms22031231. Int J Mol Sci. 2021. PMID: 33513818 Free PMC article.
References
-
- Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ et al (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropath Exp Neurol 71:362–381 - DOI
-
- LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8:499–509 - DOI
-
- Lee SJC, Nam E, Lee HJ, Savelieff MG, Lim MH (2017) Towards an understanding of amyloid-beta oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev 46:310–323 - DOI
-
- Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698–712 - DOI
-
- Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends Neurosci 28:202–208 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous